Newland Pharmaceutical Co., Ltd. (SHE:301277)
China · Delayed Price · Currency is CNY 8.65
-0.22 (-2.48%)
At close: Nov 13, 2026
Newland Pharmaceutical Financials Overview
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Revenue Revenue Growth | 733.72 | 672.38 | 726.44 | 651.44 | 627.36 | 513.84 |
Revenue Growth | 9.44% | -7.44% | 11.51% | 3.84% | 22.09% | 18.63% |
Gross Profit Gross Profit Growth | 200.61 | 225.14 | 289 | 258.6 | 223.36 | 206.02 |
Operating Income Operating Income Growth | 99.95 | 119.49 | 180.91 | 161.85 | 145.31 | 136.33 |
Net Income Net Income Growth | 93.01 | 121.25 | 173.63 | 158.98 | 132.3 | 114.98 |
Earnings Per Share EPS Growth | 0.24 | 0.31 | 0.44 | 0.41 | 0.44 | 0.39 |
EPS Growth | -23.76% | -29.54% | 8.08% | -7.22% | 12.17% | -3.36% |
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Pharmaceutical Intermediates Pharmaceutical Intermediates Growth | 657.85 | 719.43 | 643.85 | 621.21 | 508.93 |
Other Other Growth | 14.53 | 7 | - | - | - |
Total Total Growth | 672.38 | 726.44 | 651.44 | 627.36 | 513.84 |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Cash & Investments Cash & Investments Growth | 663.35 | 718.57 | 806.88 | 859.52 | 752.49 | 42.88 |
Total Debt Total Debt Growth | 3.73 | 5.69 | 2.98 | 2.72 | 5.72 | 126.38 |
Net Cash (Debt) Net Cash Growth | 659.62 | 712.88 | 803.9 | 856.8 | 746.77 | -83.5 |
Net Cash Growth | -7.06% | -11.32% | -6.17% | 14.73% | - | - |
Net Cash Per Share Net Cash Per Share Growth | 1.69 | 1.82 | 2.04 | 2.19 | 2.48 | -0.28 |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Operating Cash Flow Operating Cash Flow Growth | 68.35 | 116.94 | 126.76 | 259.46 | 82.85 | 49.08 |
Capital Expenditures CapEx Growth | -36.76 | -101.38 | -110.79 | -96.51 | -74.34 | -25.4 |
Free Cash Flow Free Cash Flow Growth | 31.59 | 15.55 | 15.97 | 162.94 | 8.5 | 23.68 |
Free Cash Flow Growth | 91.47% | -2.63% | -90.20% | 1816.39% | -64.10% | -23.36% |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Gross Margin | 27.34% | 33.48% | 39.78% | 39.70% | 35.60% | 40.09% |
Operating Margin | 13.62% | 17.77% | 24.90% | 24.85% | 23.16% | 26.53% |
Pretax Margin | 13.93% | 19.95% | 27.17% | 27.81% | 22.78% | 25.68% |
Profit Margin | 12.68% | 18.03% | 23.90% | 24.40% | 21.09% | 22.38% |
FCF Margin | 4.30% | 2.31% | 2.20% | 25.01% | 1.35% | 4.61% |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
| Period Ending | Nov '26 Nov 13, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 |
Dividend Per Share Dividend Per Share Growth | 0.200 | 0.200 | 0.400 | 0.204 | 0.170 |
Dividend Per Share Growth | -50.00% | -50.00% | 95.98% | 19.99% | - |
Dividend Yield | 2.31% | 1.70% | 4.05% | 1.92% | 1.73% |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Nov '26 Nov 13, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
PE Ratio | 36.28 | 38.13 | 22.31 | 26.19 | 29.10 | - |
P/FCF Ratio | 107.37 | 297.23 | 242.50 | 25.55 | 452.81 | - |
PS Ratio | 4.62 | 6.88 | 5.33 | 6.39 | 6.14 | - |